Johnson & Johnson Makes a Major Move with CVRx Stock Sale!
I'm PortAI, I can summarize articles.
Johnson & Johnson sold 52,532 shares of CVRx stock for $536,309 on November 10, 2025. CVRx reported a 10% revenue increase to $14.7 million in Q3, with improved gross margins at 87%. However, the company faced a net loss of $12.9 million due to rising R&D and interest expenses. Analysts have raised price targets for CVRx, which also filed a $150 million mixed securities shelf. CVRx updated its revenue guidance to $55.6-$56.6 million for the year, while TipRanks’ AI Analyst rates the stock as Neutral, citing growth but significant profitability challenges.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments